Advanced Heart Failure and Transplant Cardiology · Philadelphia, PA
NPI
1336440254
Since 2010
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3400 Spruce St, 9 Gates Bldg
Philadelphia, PA, 19104
Phone (215) 662-7355
Groups this clinician bills Medicare through
Medicare paid, 2024
$107K
1,280 services
Medicare patients, 2024
368
Average age 76
Drug cost, 2024
$6.0M
1,508 prescriptions
Company payments, 2025
$79K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy A Mazurek was code 99232 (hospital e&m - subsequent), 398 times for 151 patients. In total Jeremy A Mazurek billed 1,280 services in 27 codes, and Medicare paid $107K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 398 | 151 | $69.19 | $28K |
| 99215 Office E&M - Established | Facility | 136 | 114 | $112.98 | $15K |
| 93010 Electrocardiogram | Facility | 124 | 103 | $6.18 | $767 |
| 99223 Hospital E&M - Initial | Facility | 96 | 86 | $152.81 | $15K |
| 99291 Critical Care E&M | Facility | 91 | 27 | $186.15 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 85 | 75 | $13.17 | $1,120 |
| 99215 Office E&M - Established | Office | 62 | 48 | $123.30 | $7,645 |
| 99233 Hospital E&M - Subsequent | Facility | 57 | 34 | $99.98 | $5,699 |
| 99205 Office E&M - New | Facility | 38 | 38 | $157.44 | $5,983 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 28 | $14.52 | $450 |
| 99222 Hospital E&M - Initial | Facility | 25 | 25 | $114.67 | $2,867 |
| 93010 Electrocardiogram | Office | 25 | 25 | $6.84 | $171 |
| 99205 Office E&M - New | Office | 11 | 11 | $163.51 | $1,799 |
By year: 2022 $78K for 1,150 services; 2023 $69K for 933 services; 2024 $107K for 1,280 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy A Mazurek prescribed most often to Medicare patients was Furosemide, with 112 prescriptions and refills. In total Jeremy A Mazurek wrote 1,508 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 112 | 275 | 44 | $667 |
| Opsumit Macitentan | 111 | 119 | 17 | $1.6M |
| Adempas Riociguat | 98 | 98 | 12 | $1.4M |
| Sildenafil Citrate Generic | 97 | 161 | 25 | $37K |
| Entresto Sacubitril/Valsartan | 92 | 132 | 22 | $87K |
| Spironolactone Generic | 90 | 206 | 36 | $730 |
| Jardiance Empagliflozin | 74 | 137 | 20 | $77K |
| Metoprolol Succinate Generic | 71 | 165 | 25 | $789 |
| Eliquis Apixaban | 49 | 109 | 16 | $64K |
| Potassium Chloride Generic | 49 | 93 | 16 | $2,038 |
| Bumetanide Generic | 45 | 84 | 22 | $3,158 |
| Torsemide Generic | 41 | 98 | 15 | $1,402 |
| Farxiga Dapagliflozin Propanediol | 37 | 47 | Under 11 | $26K |
| Tyvaso Dpi Treprostinil | 34 | 34 | Under 11 | $836K |
| Ambrisentan Generic | 33 | 33 | Under 11 | $108K |
Brand drugs: 627 claims; generic drugs: 881 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy A Mazurek $79K ($79K in general payments such as food, travel and fees) from 14 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $46K.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 42 | $46K |
| Merck Sharp & Dohme LLC MRK | 18 | $21K |
| United Therapeutics Corporation UTHR | 22 | $11K |
| Abbott Laboratories ABT | 11 | $678 |
| CVRx, Inc. CVRX | 6 | $557 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $252 |
| Alnylam Pharmaceuticals Inc. ALNY | 7 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $63.29 |
| Esperion Therapeutics, Inc. ESPR | 2 | $49.13 |
| Novo Nordisk Inc NVO | 2 | $43.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.